Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies ; volume:18 ; number:1 ; day:12 ; month:2 ; year:2024 ; pages:1-20 ; date:12.2024
BMC chemistry ; 18, Heft 1 (12.2.2024), 1-20, 12.2024
- Urheber
-
Fouad, Marwa A.
Osman, Alaa A.
Abdelhamid, Noha M.
Rashad, Mai W.
Nabawy, Ashrakat Y.
El Kerdawy, Ahmed M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13065-024-01130-5
- URN
-
urn:nbn:de:101:1-2404220824420.963873728323
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fouad, Marwa A.
- Osman, Alaa A.
- Abdelhamid, Noha M.
- Rashad, Mai W.
- Nabawy, Ashrakat Y.
- El Kerdawy, Ahmed M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore
Tautomerism in structure-based 3D pharmacophore modeling
Combining docking with pharmacophore filtering for improved virtual screening
Building shape-focused pharmacophore models for effective docking screening
Glide XP fragment docking and structurebased pharmacophores
Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation
Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands
Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures
Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies
Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore
Tautomerism in structure-based 3D pharmacophore modeling
Combining docking with pharmacophore filtering for improved virtual screening
Building shape-focused pharmacophore models for effective docking screening
Glide XP fragment docking and structurebased pharmacophores
Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation
Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands
Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures
Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies
Evaluation of the performance of 3D virtual screening programs: docking vs. structure-based pharmacophore
Tautomerism in structure-based 3D pharmacophore modeling
Combining docking with pharmacophore filtering for improved virtual screening
Building shape-focused pharmacophore models for effective docking screening
Glide XP fragment docking and structurebased pharmacophores
Efficient 3D pharmacophore alignment as a tool for structure-based modeling and scoring
In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation
Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands
Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures